About this trial
The ALADIM trial is a hybrid type II effectiveness-implementation cluster-randomized controlled, parallel, two arm, superiority trial. The clusters consist of 10 Primary Care Centers (PCCs) of Mallorca (Balearic Islands, Spain), which are randomly assigned to either the intervention or the control group in a 1:1 ratio. The intervention group (5 PCCs) receives training and supporting material to facilitate the implementation of the adapted DPP and effectively deliver the program over a 12-month period. The control group (5 PCCs) continues providing usual care, in line with standard healthcare practices. Effectiveness outcomes are assessed at participant level according to a cluster-randomized controlled design with data collection at baseline, 6-month and 12-month during the intervention period, and at 18-month follow-up to evaluate mid-term effects post-intervention. Implementation outcomes are assessed at PCC level throughout the study period. Prior to the hybrid trial, the DPP will be culturally and contextually adapted to the Spanish Primary Care setting.
The DPP will be culturally adapted using the Intervention Mapping ADAPT (IM-ADAPT) approach. Simultaneously, the implementation strategy will be designed using the Implementation Mapping approach.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Adapted Diabetes Prevention Program
BehavioralParticipants assigned to this group will participate in a group-based behavioural change program to improve diet and increase physical activity levels during 12 months.
Usual Care
BehavioralParticipants assigned to this groups will receive usual care according to national guidelines
Treatment groups
Trial outcomes
Primary outcomes
Weight
Change in body weight at 6 and 12 months versus baseline
Implementation fidelity
Degree to which the adapted DPP is delivered as intended.
Secondary outcomes
Spill-over effect
Change in the percentage of individuals with prediabetes receiving lifestyle advice from their healthcare professional.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of the Balearic Islands
Lead sponsor
Instituto de Salud Carlos III
Collaborator
This trial is not recruiting at the moment. You can still explore other options: